Variable | Progression free survival | Overall survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Presenting symptom | 2.219 | 1.220–4.037 | 0.009 | |||
ROD, ≥ 1.34 | 3.068 | 2.102–4.478 | < 0.001 | 1.774 | 1.175–2.676 | 0.006 |
WHO/ISUP grade, III/IV | 2.102 | 1.512–2.922 | < 0.001 | 2.699 | 1.880–3.874 | < 0.001 |
Tumor necrosis | 1.315 | 0.933–1.854 | 0.118 | 2.046 | 1.395–3.002 | < 0.001 |
Sarcomatoid differentiation | 1.529 | 1.031–2.268 | 0.035 | 1.123 | 0.710–1.776 | 0.621 |
MSKCC score, intermediate and poor | 1.619 | 1.137–2.305 | 0.008 | 1.901 | 1.261–2.864 | 0.002 |
IMDC score, intermediate and poor | 2.315 | 1.427–4.438 | < 0.001 | 2.004 | 1.258–4.062 | < 0.001 |